CFM
NUVB icon

Capricorn Fund Managers’s Nuvation Bio NUVB Stock Holding History

Capricorn Fund Managers’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,588,854
Closed -$14.2M – 135
2025
Q4 		$14.2M Buy
+1,588,854
New +$9.84M 3.43% 4

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capricorn Fund Managers's NUVB Position: Q1 2026 in Review

Capricorn Fund Managers sold out of Nuvation Bio (NUVB) in Q1 2026, closing a stake of 1,588,854 shares — an estimated $14.2M sold.

Capricorn Fund Managers first reported a position in NUVB in Q4 2025 and held it in 1 quarter. The position peaked at $14.2M in Q4 2025. 233 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Capricorn Fund Managers reported no remaining Nuvation Bio position as of Q1 2026 after selling out during the quarter.
  • Capricorn Fund Managers sold 1,588,854 Nuvation Bio shares in Q1 2026, an estimated $14.2M.
  • Capricorn Fund Managers first reported a position in Nuvation Bio in Q4 2025 and held it in 1 quarter.
  • Capricorn Fund Managers's Nuvation Bio position peaked at $14.2M in Q4 2025.
  • 233 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Capricorn Fund Managers's 13F filing for Q1 2026, filed 24 Apr 2026.